For mandipropamid a dossier was submitted by Syngenta AG to the authorities of Austria on 13 December 2005 with an application to obtain its inclusion in Annex I to Directive 91/414/EEC.
Article 2 The rapporteur Member States shall pursue the detailed examination for the dossiers concerned and shall report the conclusions of their examinations accompanied by any recommendations on the inclusion or non-inclusion of the active substance concerned in Annex I of Directive 91/414/EEC and any conditions related thereto to the European Commission as soon as possible and at the latest within a period of one year from the date of publication of this Decision in the Official Journal of the European Union.
Article 3 This Decision is addressed to the Member States.
Done at Brussels, 31 August 2006.
For the Commission Markos Kyprianou Member of the Commission [1] OJ L 230, 19.8.1991, p. 1.
Directive as last amended by Commission Directive 2006/41/EC (OJ L 187, 8.7.2006, p. 24). -------------------------------------------------- ANNEX ACTIVE SUBSTANCES CONCERNED BY THIS DECISION No | Common Name, CIPAC Identification Number | Applicant | Date of application | Rapporteur Member State | 1 | Aviglycine HCl CIPAC-No: 601 | Valent BioSciences | 27.10.2004 | UK | 2 | Mandipropamid CIPAC-No: not yet allocated | Syngenta AG | 13.12.2005 | AT | 3 | Meptyldinocap CIPAC-No: not yet allocated | Dow AgroSciences | 12.8.2005 | UK | --------------------------------------------------
